
NHS funds MS drug that can help some patients walk
The NHS in England will provide fampridine, the first MS treatment shown to improve walking for some patients, potentially helping up to about 5,000 people per year. Eligibility depends on the degree of walking difficulty, and patients will undergo a one-month trial to confirm clear benefit before continuing.













